Lymphoma patients to benefit from new cancer therapy

Australian Government

5 August 2021 - Australians suffering from a rare type of blood cancer will now have access to a highly specialised CAR-T cell therapy, as the Morrison Government continues to invest in medical breakthroughs and new therapies that save lives and improve lives.

Yescarta (axicabtagene ciloleucel) is a type of CAR-T cell therapy that is used to treat patients with certain types of lymphoma—a form of blood cancer.

As part of the National Health Reform Agreement, our Government is ensuring more Australian patients can access Yescarta, a high cost and highly specialised therapy.

Read Minister of Health press release

Michael Wonder

Posted by:

Michael Wonder